Abstract
Background
Serum oxidative stress (OS) level has an important role in the inflammatory process of heart failure.
Hypothesis
The study was designed to analyze serum OS levels in chronic heart failure (HF) patients and to examine the relation between OS levels and other clinical and prognostic parameters of HF.
Methods
We studied 82 consecutive chronic symptomatic HF patients with systolic LV dysfunction (ejection fraction <45%). The serum OS level was determined using thermochemiluminescence assay. We compared the serum OS levels with patients' clinical and prognostic parameters.
Results
Higher serum OS levels were associated with higher New York Heart Association class (P = .01), worse renal function (serum urea, creatinine, and creatinine clearance) (P<.001) and higher serum levels of hs‐C‐reactive protein and N‐terminal pro brain natriuretic peptide (P = .001, P<.001, respectively).
Conclusions
In chronic systolic HF patients, high serum OS levels correlate with advanced disease and known markers of poor prognosis. Copyright © 2009 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (1.1 MB).
References
- 1. Valgimigli M, Merli E, Malagutti P, et al. Hydroxyl radical generation, levels of tumor necrosis factor‐alpha, and progression to heart failure after acute myocardial infarction. J Am Coll Cardiol. 2004; 43: 2000–2008. [DOI] [PubMed] [Google Scholar]
- 2. Fragasso G, Palloshi A, Puccetti P, et al. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. J Am Coll Cardiol. 2006; 48: 992–998. [DOI] [PubMed] [Google Scholar]
- 3. Li Y, Takemura G, Okada H, et al. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res. 2006; 71: 684–694. [DOI] [PubMed] [Google Scholar]
- 4. Pacher P, Schulz R, Liaudet L, Szabo C. Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci. 2005; 26: 302–310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Jonsson G, Abdelnoor M, Seljeflot I, et al. The antioxidative effects of long‐term treatment are more pronounced for carvedilol than for atenolol in post‐myocardial infarction patients. J Cardiovasc Pharmacol. 2007; 49: 27–32. [DOI] [PubMed] [Google Scholar]
- 6. Flammer AJ, Hermann F, Wiesli P, et al. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension. J Hypertens. 2007; 25: 785–791. [DOI] [PubMed] [Google Scholar]
- 7. Shnizer S, Kagan T, Lanir A, Maor I, Reznick AZ. Modifications and oxidation of lipids and proteins in human serum detected by thermochemiluminescence. Luminescence. 2003; 18: 90–96. [DOI] [PubMed] [Google Scholar]
- 8. Reznick AZ, Brook G, Hochman A, et al. Thermocemiluminescence (TCL) oxidizability assay–clinical laboratory studies. In: Osben T, Chevion M, eds. NATO Science Series: Frontiers in Neurodegenerative Diseases and Aging: Fundamental Aspects, Clinical Perspectives and New Insights. Series I: Life and Behavioral Sciences. Amsterdam, The Netherlands: IOS Press; 2004; 40–55. [Google Scholar]
- 9. Lissak A, Wiener‐Megnazi Z, Reznick AZ, et al. Oxidative stress indices in seminal plasma, as measured by the thermochemiluminescence assay, correlate with sperm parameters. Fertil Steril. 2004; 81: 792–797. [DOI] [PubMed] [Google Scholar]
- 10. Wiener‐Megnazi Z, Vardi L, Lissak A, et al. Oxidative stress indices in follicular fluid as measured by the thermochemiluminescence assay correlate with outcome parameters in vitro fertilization. Fertil Steril. 2004; 82: 1171–1176. [DOI] [PubMed] [Google Scholar]
- 11. van den Broek SA, van Veldhuisen DJ, de Graeff PA, et al. Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1992; 70: 359–363. [DOI] [PubMed] [Google Scholar]
- 12. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 1997; 96: 509–516. [DOI] [PubMed] [Google Scholar]
- 13. Hillege HL, Nitsch D, Pfeffer MA, et al. Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006; 113: 671–678. [DOI] [PubMed] [Google Scholar]
- 14. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N‐terminal pro‐B‐type natriuretic peptide and long‐term mortality in stable coronary heart disease. N Engl J Med. 2005; 352: 666–675. [DOI] [PubMed] [Google Scholar]
- 15. Nonaka‐Sarukawa M, Yamamoto K, Aoki H, et al. Increased urinary 15‐F2t‐isoprostane concentrations in patients with non‐ischaemic congestive heart failure: a marker of oxidative stress. Heart. 2003; 89: 871–874. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Hokamaki J, Kawano H, Yoshimura M, et al. Urinary biopyrrins levels are elevated in relation to severity of heart failure. J Am Coll Cardiol. 2004; 43: 1880–1885. [DOI] [PubMed] [Google Scholar]
- 17. Wijeysundera HC, Hansen MS, Stanton E, et al. Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. Am Heart J. 2003; 146: 291–297. [DOI] [PubMed] [Google Scholar]
- 18. Ellis GR, Anderson RA, Lang D, et al. Neutrophil superoxide anion–generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short‐ and long‐term vitamin C therapy. J Am Coll Cardiol. 2000; 36: 1474–1482. [DOI] [PubMed] [Google Scholar]
- 19. Dalle‐Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem. 2006; 52: 601–623. [DOI] [PubMed] [Google Scholar]
- 20. Mihm MJ, Coyle CM, Schanbacher BL, Weinstein DM, Bauer JA. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc Res. 2001; 49: 798–807. [DOI] [PubMed] [Google Scholar]
- 21. Long X, Goldenthal MJ, Wu GM, Marin‐Garcia J. Mitochondrial Ca2+ flux and respiratory enzyme activity decline are early events in cardiomyocyte response to H2O2. J Mol Cell Cardiol. 2004; 37: 63–70. [DOI] [PubMed] [Google Scholar]
- 22. Tsutsui H. Mitochondrial oxidative stress and heart failure. Intern Med. 2006; 45: 809–813. [DOI] [PubMed] [Google Scholar]
- 23. Mallat Z, Philip I, Lebret M, et al. Elevated levels of 8‐iso‐prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation. 1998; 97: 1536–1539. [DOI] [PubMed] [Google Scholar]
- 24. Kameda K, Matsunaga T, Abe N, et al. Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling. Eur Heart J. 2003; 24: 2180–2185. [DOI] [PubMed] [Google Scholar]
- 25. Ferrari R, Guardigli G, Mele D, et al. Oxidative stress during myocardial ischaemia and heart failure. Curr Pharm. 2004; 10: 1699–1711. [DOI] [PubMed] [Google Scholar]
- 26. Boger RH, Schwedhelm E, Maas R, Quispe‐Bravo S, Skamira C. ADMA and oxidative stress may relate to the progression of renal disease: rationale and design of the VIVALDI study. Vasc Med. 2005; 10: S97–S102. [DOI] [PubMed] [Google Scholar]
- 27. Domenici FA, Vannucchi MT, Jordao AA Jr, Meirelles MS, Vannucchi H. DNA oxidative damage in patients with dialysis reatment. Ren Fail. 2005; 27: 689–694. [DOI] [PubMed] [Google Scholar]
- 28. Cottone S, Palermo A, Vaccaro F, et al. In renal transplanted patients inflammation and oxidative stress are interrelated. Transplant Proc. 2006; 38: 1026–1030. [DOI] [PubMed] [Google Scholar]
- 29. Abrams J. C‐reactive protein, inflammation, and coronary risk: an update. Cardiol Clin. 2003; 21: 327–331. [DOI] [PubMed] [Google Scholar]